Loading organizations...
Huayao Capital: Investment firm focused on early-stage technology and life sciences companies, investing in biotech and gene therapy ventures.
Based on the provided Perplexity Research, a comprehensive "About" section for "Huayao Capital" cannot be generated, as the search results explicitly indicate a complete absence of information regarding an organization by that specific name. The research did, however, identify Hua Yi Le Jian, a distinct gene therapy biotech company founded in 2019, which is explicitly stated to be a different entity from "Huayao Capital." It is crucial to understand that while Hua Yi Le Jian is a recognizable name found, its details cannot be attributed to the requested "Huayao Capital" due to this clear distinction. To accurately fulfill the request for an "About" section, specific and verifiable search results directly covering "Huayao Capital" are indispensable. This would require factual details concerning its business operations, leadership, funding, and recent activities, without which an accurate or compliant summary remains impossible.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 10, 2021 | Weihansi Shengwu | $15.6M Pre-Series B | Huayao Capital | — |